TCTMD7 小时
HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt
The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.
rheumatologyadvisor14 小时
Sildenafil Shows Potential for Improving Cardiac Outcomes in Systemic Sclerosis
Sildenafil was effective for reducing diastolic dysfunction and altered ejection fraction among patients with SSc.
Heart Failure Deaths Are Increasing. New Treatments Could Help.
The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...